Nicorandil ameliorates hypertension-related bladder dysfunction in the rat

Neurourology and Urodynamics

Volumn 31, Issue 5, 2012, Pages 695-701

  Saito, Motoaki ^a   Ohmasa, Fumiya ^a   Tsounapi, Panagiota ^a   Inoue, Seiya ^a   Dimitriadis, Fotios ^a   Kinoshita, Yukako ^a   Satoh, Keisuke ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

K ATP channel; Nerve growth factor; Nicorandil ameliorates hypertension related detrusor overactivity in the rat; Spontaneously hypertensive rat (shr)

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBACHOL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; NERVE GROWTH FACTOR; NICORANDIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER DYSFUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; HYDROGEN CLEARANCE; HYPERTENSION; LOW DRUG DOSE; MALE; MICTURITION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTENSION; KATP CHANNELS; MALE; NERVE GROWTH FACTOR; NICORANDIL; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, INBRED SHR; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REGIONAL BLOOD FLOW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINATION; URODYNAMICS;

EID: 84862571699     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21213     Document Type: Article

References (38)

1. Abrams P, Cardozo L, Fall M, et al. Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodynam 2002;21:167-78. (Pubitemid 34195211)
2. Andersson KE. Antimuscarinic mechanisms and the overactive detrusor: An update. Eur Urol 2011;59:377-86.
3. Chapple CR, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62.
4. Azadzoi KM, Tarcan T, Siroky MB, et al. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol 1999;161:1626-35. (Pubitemid 29420853)
5. Azadzoi KM, Tarcan T, Kozlowski R, et al. Overactivity and structural changes in the chronically ischemic bladder. J Urol 1999;162:1768-78. (Pubitemid 29474727)
6. Azadzoi KM, Shinde VM, Tarcan T, et al. Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder. J Urol 2003;169:1885-91. (Pubitemid 36443539)
7. Yoshida M, Masunaga K, Nagata T, et al. The effects of chronic hyperlipidemia on bladder function in myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits. Neurourol Urodynam 2010;29:1350-4.
8. Tarcan T, Azadzoi KM, Siroky MB, et al. Age-related erectile and voiding dysfunction: The role of arterial insufficiency. Br J Urol 1998;82:26-33.
9. Steers WD, Clemow DB, Persson K, et al. The spontaneously hypertensive rat: Insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Exp Physiol 1999;84:137-47. (Pubitemid 29054295)
10. Yono M, Yamamoto Y, Yoshida M, et al. Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract. Life Sci 2007;81:218-22. (Pubitemid 46976980)
11. Pinggera GM, Mitterberger M, Pallwein L, et al. alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int 2008;101:319-24.
12. Okutsu H, Matsumoto S, Hanai T, et al. Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Urology 2010;75:235-40.
13. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989;63:18-24.
14. Markham A, Plosker GL, Goa KL. Nicorandil: An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs 2000;60:955-74.
15. Yu Y, de Groat WC. Effects of ZD6169, a KATP channel opener, on bladder hyperactivity and spinal c-fos expression evoked by bladder irritation in rats. Brain Res 1998;807:11-8. (Pubitemid 29005231)
16. Darblade B, Behr-Roussel D, Oger S, et al. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: Potential therapeutic targets for overactive bladder. Urology 2006;68:442-8. (Pubitemid 44175516)
17. Wojdan A, Freeden C, Woods M, et al. Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat. J Pharmacol Exp Ther 1999;289:1410-8. (Pubitemid 29246672)
18. + channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction. Neurourol Urodynam 2003;22:147-55.
19. Kamiyama Y, Muto S, Masuda H, et al. Inhibitory effects of nicorandil, a K ATP channel opener and a nitric oxide donor, on overactive bladder in animal models. BJU Int 2008;101:360-5.
20. Jin LH, Andersson KE, Kwon YH, et al. Selection of a control rat for conscious spontaneous hypertensive rats in studies of detrusor overactivity on the basis of measurement of intra-abdominal pressures. Neurourol Urodynam 2010;29:1338-43.
21. Saito M, Suzuki H, Yamada M, et al. Effect of cyclohexenonic long-chain fatty alcohol on rat overactive bladder induced by bladder neck obstruction. Eur J Pharmacol 2004;501:143-9. (Pubitemid 39298947)
22. Saito M, Okada S, Kazuyama E, et al. Pharmacological properties, functional alterations and gene expression of muscarinic receptors in young and old type 2 Goto-Kakizaki diabetic rat bladders. J Urol 2008;180:2701-5.
23. Aukland K, Bower BF, Berliner RW. Measurement of local blood flow with hydrogen gas. Circ Res 1964;14:164-87.
24. Hori K, Saito S, Kubota K. A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs. Br J Cancer 2002;86:1604-14. (Pubitemid 34628115)
25. Shinbori C, Saito M, Kinoshita Y, et al. Cyclohexenonic long-chain fatty alcohol has therapeutic effects on diabetes-induced angiopathy in the rat aorta. Eur J Pharmacol 2007;567:139-44. (Pubitemid 46782830)
26. Zhou Q, Satake N, Shibata S. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery. Eur J Pharmacol 1995;273:153-9.
27. Faruqui AR, Mathai J, George J, et al. Inhibitory effect of nicorandil on the contraction of isolated human urinary bladder detrusor muscle. Methods Find Exp Clin Pharmacol 2008;30:363-6.
28. Sudo H, Yogo K, Ishizuka N, et al. Nicorandil, a potassium channel opener and nitric oxide donor, improves the frequent urination without changing the blood pressure in rats with partial bladder outlet obstruction. Biol Pharm Bull 2008;31:2079-82.
29. Persson K, Pandita RK, Spitsbergen JM, et al. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol 1998;275:R1366-73.
30. Schneider T, Hein P, Bai J, et al. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction? J Urol 2005;173:2178-81. (Pubitemid 40675277)
31. Yono M, Yamamoto Y, Imanishi A, et al. Differential effects of prazosin and naftopidil on pelvic blood flow and nitric oxide synthase levels in spontaneously hypertensive rats. J Recept Signal Transduct Res 2008;28:403-12.
32. Kuo HC, Liu HT, Chancellor MB. Can urinary nerve growth factor be a biomarker for overactive bladder? Rev Urol 2010;12:e69-77.
33. Ishida T, Shimoda N, Sato K, et al. Effects of ischemia on voiding function and nerve growth factor of the rat urinary bladder. Nippon Hinyokika Gakkai Zasshi 1999;90:564-71. (Pubitemid 29274729)
34. Gomma AH, Purcell HJ, Fox KM. Potassium channel openers in myocardial ischaemia: Therapeutic potential of nicorandil. Drugs 2001;61:1705-10. (Pubitemid 32980502)
35. Isomoto S, Kondo C, Yamada M, et al. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem 1996;271:24321-4. (Pubitemid 26333158)
36. + channel pore 6.1/sulfonylurea receptor 2A in pig detrusor smooth muscle cells: Uncoupling of cAMP signal pathways. J Pharmacol Exp Ther 2008;327:114-23.
37. Scott VE, Davis-Taber RA, Silvia C, et al. Characterization of human urinary bladder KATP channels containing SUR2B splice variants expressed in L-cells. Eur J Pharmacol 2004;483:195-205. (Pubitemid 38068400)
38. + channel opener, on membrane currents in human detrusor myocytes. Br J Pharmacol 2006;149:542-50.